Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Unspecified Adult Solid Tumor, Protocol Specific × Tissue Plasminogen Activator × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Unspecified Adult Solid Tumor, Protocol Specific 1

Interventions

sargramostim 2 Topotecan 2 timcodar 1 Tissue Plasminogen Activator 1 Radiotherapy 1 Radiosurgery 1 Paclitaxel 1 Muromonab-CD3 1 Irinotecan 1 Interferon-alpha 1 Immunization, Passive 1 Gemcitabine 1 Docetaxel 1 Diathermy 1 Cyclophosphamide 1 Cisplatin 1 Captopril 1 Biological Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00086723 2012-06-11

In Vivo Angiostatin Generation Using Tissue Plasminogen Activator and Captopril in Treating Patients With Progressive Metastatic Cancer

Northwestern University

Phase 1/2 Completed

Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon ⚡